Literature DB >> 15712911

[Determination of verapamil in dog serum and tissues by reversed-phase high performance liquid chromatography].

Xin Sun1, Qingsheng Yin, Dianliang Chen, Xuejun Dong, Lichun Zhou, Hui Zhang, Pingsheng Fan.   

Abstract

A method for determination of verapamil (VRPM) concentrations in dog serum and tissues was established. The study was carried out on a high performance liquid chromatograph with a reversed-phase C18 column, a mobile phase of acetate-methanol-triethylamine (40:60:1, v/v) at 1.0 mL/min, and UV detection at 228 nm. Diazepam was used as the internal standard. The detection limits of VRPM concentrations in serum and tissues were determined to be 50 microg/L and 50 ng/g, respectively. Good linearities were observed for VRPM in serum and in liver tissue (r > 0.999). The precision of the method was good and the recoveries of VRPM were higher than 90.80%. This method is rapid, accurate and convenient for determination of VRPM concentrations in serum and tissues.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15712911

Source DB:  PubMed          Journal:  Se Pu        ISSN: 1000-8713


  3 in total

1.  CDKN2B is critical for verapamil-mediated reversal of doxorubicin resistance in hepatocellular carcinoma.

Authors:  Tengyue Zhang; Kelong Ma; Jin Huang; Shitang Wang; Yabei Liu; Gaofei Fan; Miao Liu; Guangshan Yang; Cheng Wang; Pingsheng Fan
Journal:  Oncotarget       Date:  2017-10-26

2.  Upregulation of Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Mediates the Reversal Effect of Verapamil on Chemo-Resistance to Adriamycin of Hepatocellular Carcinoma.

Authors:  Guangshan Yang; Gaofei Fan; Tengyue Zhang; Kelong Ma; Jin Huang; Miao Liu; Xiaolu Teng; Kun Xu; Pingsheng Fan; Dongmiao Cheng
Journal:  Med Sci Monit       Date:  2018-04-08

3.  Clinical evaluation of targeted arterial perfusion of verapamil and chemotherapeutic drugs in interventional therapy of advanced lung cancer.

Authors:  Jin Huang; Tengyue Zhang; Kelong Ma; Pingsheng Fan; Yabei Liu; Chengtao Weng; Gaofei Fan; Qiaohong Duan; Xianhai Zhu
Journal:  Cancer Chemother Pharmacol       Date:  2013-08-22       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.